Dietetic Counseling Proves Worthwhile in Kidney Disease

This article originally appeared here.
Share this content:
Dietetic Counseling Proves Worthwhile in Kidney Disease
Dietetic Counseling Proves Worthwhile in Kidney Disease

FRIDAY, Feb. 17, 2017 (HealthDay News) -- It is clinically worthwhile for patients with chronic kidney disease (CKD) to be counseled on reducing salt intake, according to research published online Feb. 16 in the Clinical Journal of the American Society of Nephrology.

Fifty-eight adults with CKD in Michigan and North Carolina participated in the study. Each was randomly assigned to follow a salt-restricted diet or their usual diet over a four-week period. Then, after a two-week hiatus, each patient switched to the other diet. During the salt-restricted diet, the goal was to consume less than 2 g of salt a day. Dietitians trained in motivational techniques counseled them on cutting salt in their diets and encouraged them to make lower-sodium choices.

The researchers found that participants lowered their systolic blood pressure by 10.8 points, on average, on a salt-restricted diet versus their usual diet. They also flushed out a liter of water from their bodies, on average, by reducing salt in their diets.

"In this randomized crossover trial, implementation of sodium-restricted diet in patients with CKD stage 3 to 4 resulted in clinically and statistically significant improvement in blood pressure and hydration status," the authors write. "This simple dietary intervention merits a larger trial in CKD to evaluate effects on major clinical outcomes."

Two authors reported holding stock in Fresenius Medical Care, a kidney dialysis company.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »